Health

  • SII to apply for Oxford vaccine trials in India in a week
    New Delhi, July 20 (IANS) The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of the AstraZeneca-Oxford Covid vaccine.   Commenting on the AstraZeneca-Oxford vaccine's results, Adar Poonawalla, CEO, Serum Institute of India, said, "The trials have shown promising results and we are extremely happy about it. We will be applying for the licensure trials to the Indian regulator in a week's time. As soon as they grant
  • First human trial of Oxford COVID-19 vaccine shows promise
    LONDON, July 20 (Reuters) - An experimental coronavirus vaccine being developed by AstraZeneca and Oxford university was safe and produced an immune response in early-stage clinical trials, data showed on Monday, keeping alive the hope it could be in use by the end of the year.   The vaccine, called AZD1222, has been described by the World Health Organization's chief scientist as the leading candidate in a global race to halt a pandemic that has claimed more than 600,000
  • Hyderabad's NIMS begins clinical trials of Covid vaccine
    Hyderabad, July 20 (IANS) As part of human trials of Covaxin, India's first indigenous Covid-19 vaccine, two volunteers were given its first dose at the Nizam's Institute of Medical Sciences (NIMS) on Monday, doctors said.   The healthy volunteers, who were administered the first dose of the vaccine in the morning, were stable. "Both are stable and we have not found any reaction or side-effects," said Dr G. Srinivas, a member of the research team conducting
  • Covid-19: Synairgen announces positive results from clinical trial
    London, July 20 (IANS) UK-based Synairgen on Monday announced positive results from a clinical trial of SNG001, which helped reduce the risk of developing severe diseases in hospitalised Covid-19 patients.   The treatment from Southampton-based Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection, the BBC reported. The protein is inhaled directly into the lungs of patients with Covid-19 virus, using a nebuliser, in the hope t
  • Lancet editor creates buzz with vaccine tweet
    London, July 20 (IANS) Medical journal The Lancet's chief editor has dropped a tweet that appears to confirm the speculation that Phase-1 clinical trial results of the Covid-19 vaccine developed by scientists at the Oxford University will be published on Monday.   The Oxford vaccine candidate is believed to be leading the race among over 100 such candidates to find an effective protection against the deadly disease.   "Tomorrow. Vaccines. Just saying,&quo
  • UK signs deals for 90mn COVID-19 vaccine doses
    London, July 20 (IANS) The UK government has signed deals for 90 million doses of promising coronavirus vaccines that are being developed, the media reported on Monday.   The vaccines are being researched by an alliance between the pharmaceutical companies BioNtech and Pfizer as well as the firm Valneva, reports the BBC.   The new deal is on top of 100 million doses of the Oxford University vaccine being developed by AstraZeneca.   However, it is still
  • All you need to know about migraine
    New Delhi, July 20 (IANSlife) Headache is a blanket term used to describe pain on one or both sides of the head and upper part of the neck. According to the WHO, every adult experiences headache at some point of time in life.   The common causes of headaches are stress and anxiety, emotional distress, irregular eating habits, dehydration, high blood pressure, hot weather etc, Dr Pradeep Mahajan, Regenerative Medicine Researcher, Mumbai told IANSlife.   According t
  • 'COVID vaccine to reach usable stage after 2020'
    New Delhi, July 19 (IANS) While India is set to begin the trials of its indigenous coronavirus vaccine from this week, a top official from the Indian Medical Association (IMA) has claimed that a vaccine cure for the deadly COVID-19 upon its development and marketing would reach usable stage only after 2020.   "A usable vaccine to cure COVID-19 and bringing the same to good use would go beyond 2020. Developing a vaccine for viral infections is a longer process as firstly
  • 7 Indian pharma players race to develop COVID-19 vaccine
    New Delhi, July 19 (PTI) At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally.   Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.   Vacc
  • Contact tracing won't curb corona if testing is too slow: Lancet
    London, July 18 (IANS) The speed of contact tracing strategies is essential to slow coronavirus transmission, but the delays in Covid-19 testing will significantly hamper this process, warn researchers.   If Covid-19 testing is delayed by three days or more after a person develops symptoms, even the most efficient contact tracing strategy cannot reduce onward transmission of the virus, the study, published in The Lancet Public Health journal, reported.   According
  • Covid-19 cannot be transmitted from mosquitoes to humans: Study
    New York, July 18 (IANS) Do mosquitoes carry the novel coronavirus and can they transmit Covid-19 to humans? Maybe not. In a new study, the researchers have confirmed that Covid-19 virus cannot be transmitted to people by mosquitoes.   The findings, published in the journal Scientific Reports, provide the first experimental investigation on the capacity of SARS-CoV-2, the virus that causes Covid-19 disease, to infect and be transmitted by mosquitoes.   "While
  • Oxford COVID-19 vaccine hopes rise with strong trial results
    New Delhi, July 16 (PTI): Researchers at the University of Oxford believe they may have a breakthrough in their search for a COVID-19 vaccine after the team discovered that the jab could provide 'double protection' against the deadly coronavirus following early stage human trials, according to media reports in the United Kingdom.   Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodi
  • Early-stage trial data on AstraZeneca COVID-19 vaccine due Monday - Lancet
    LONDON, July 16 (Reuters) - Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.   The vaccine candidate is already in large-scale Phase III human trials to assess whether it can protect against COVID-19, but its developers have yet to report Phase I results which would show whether it is safe and whether or not it induces an immune response.   &ld
  • US stocks rally after promising Covid vaccine results from Moderna
    New York, July 15 (IANS) The Wall Street on Wednesday cheered the promising early results from US-based pharmaceutical major Moderna's experimental vaccine, mRNA-1273, and solid earnings from Goldman Sachs Group.   The Dow Jones Industrial Average jumped 338 points in early-morning trading. The S&P 500 rose 1.1 per cent while the Nasdaq Composite advanced 0.9 per cent, reports CNBC.   The three main US stock indexes have recovered most of their losses from
  • No evidence to support Covid-19 spread from dogs to humans
    New York, July 15 (IANS) A study published earlier this year claiming the coronavirus (Covid-19) may have jumped from dogs to humans is scientifically flawed, offering no direct evidence to support its conclusions, say researchers.   "During this time of Covid-19 we are seeing people publish things that make wild leaps to conclusions that are not justified by the evidence and this seems to be one of them," said study researcher David Pollock from the University of
  • Anxiety may be symptoms of Covid-19 impact on brain: Study
    New York, July 15 (IANS) Depressed mood or anxiety exhibited in Covid-19 patients may possibly be a sign the virus affects the central nervous system, according to a new study.   The findings, published in the journal The Laryngoscope, revealed that these two psychological symptoms were most closely associated with a loss of smell and taste rather than the more severe indicators of the novel coronavirus such as shortness of breath, cough or fever.   "The unex
  • Surge in HIV, TB, malaria deaths due to Covid-19: Lancet
    London, July 14 (IANS) Some low- and middle-income countries (LMICs) could experience a surge in HIV, tuberculosis (TB), and malaria deaths over the next five years because of disruption to health services caused by the Covid-19 pandemic, according to a new study, published in The Lancet Global Health journal.   The researchers have estimated that in areas heavily affected by these major infectious diseases, the impact of Covid-19 disruption on years of life lost could be of
  • Only 3% Indians realise the importance of consuming adequate protein: Study
    New Delhi, July 14 (IANSlife) Although 95 per cent of Indian mothers claim to know protein as a macro-nutrient, only three per cent of the population really understands the prominent functions of protein or why one should consume it daily, reveals a new study.   Across cities, 82 per cent mothers residing in mini-metros such as Ahmedabad, Bengaluru and Hyderabad were unable to correctly associate protein with its functions and attributed low importance to its consumption as
  • WHO warns that coronavirus crisis may get 'worse and worse and worse'
    GENEVA/ZURICH, July 13 (Reuters) - The new coronavirus pandemic raging around the globe will worsen if countries fail to adhere to strict healthcare precautions, the World Health Organization (WHO) warned on Monday.   "Let me be blunt, too many countries are headed in the wrong direction, the virus remains public enemy number one," WHO Director General Tedros Adhanom Ghebreyesus told a virtual briefing from the U.N. agency's headquarters in Geneva.  
  • Stress hormone linked to higher blood sugar in diabetics
    New York, July 13 (IANS) Researchers have showcased a clear link between the stress hormone cortisol and higher blood sugar levels in people with type 2 diabetes.   Previous research has shown that stress and depression are two of the major causes of a flatter cortisol profile.   "In healthy people, cortisol fluctuates naturally throughout the day, spiking in the morning and falling at night," said study researcher Joshua J Joseph from the Ohio State Uni